Literature DB >> 26142070

Examining Trends and Coexisting Conditions Among Children Qualifying for SSI Under ADHD, ASD, and ID.

Christian D Pulcini1, James M Perrin2, Amy J Houtrow3, John Sargent4, Amy Shui2, Karen Kuhlthau2.   

Abstract

OBJECTIVE: To examine the prevalence trends and coexisting conditions in attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and intellectual disability (ID) in the pediatric Supplemental Security Income (SSI) population and general population.
METHODS: The Social Security Administration (SSA) provided data on primary and secondary diagnoses of children qualifying for SSI for years 2000 to 2011. We compared SSA data with 2000-2011 National Health Interview Survey data on the prevalence of mental health diagnoses among children in the general population living between 0 and 199% of the federal poverty line. We utilized linear regression analysis to test the statistical significance of differences in the trends of the conditions' prevalence.
RESULTS: Over this time period, the SSI population experienced increases in ADHD (5.8%) and ASD (7.2%) and a decrease in ID (-10.3%). Comparison with change in the general population indicated no significant difference in ADHD but significant differences in ASD and ID. Relative percentage changes reflect similar changes. The SSI population qualifying for SSI with ADHD (70.8%) had higher rates of coexisting conditions than the general population (66.1%), but lower rates of coexisting conditions for ASD and ID.
CONCLUSIONS: ADHD is on the rise among children receiving SSI and in the general population. This suggests that the rise of ADHD in the SSI population is expected and does not represent a misallocation of resources. Changes described among the SSI population in ASD and ID may allude to diagnostic/coding trends and/or true changes in prevalence. Limitations arise from the comparability of the 2 data sets.
Copyright © 2015 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; SSI; autism; children; coexisting condition; disability; intellectual disability; mental health impairments

Mesh:

Year:  2015        PMID: 26142070     DOI: 10.1016/j.acap.2015.05.002

Source DB:  PubMed          Journal:  Acad Pediatr        ISSN: 1876-2859            Impact factor:   3.107


  6 in total

1.  From evidence to impact: Joining our best school mental health practices with our best implementation strategies.

Authors:  Aaron R Lyon; Eric J Bruns
Journal:  School Ment Health       Date:  2019-01-01

2.  ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors.

Authors:  Tanya S Hauck; Cindy Lau; Laura Li Foa Wing; Paul Kurdyak; Karen Tu
Journal:  Can J Psychiatry       Date:  2017-01-19       Impact factor: 4.356

3.  Responsibility for Asthma Management Among Adolescents With and Without Attention-Deficit/Hyperactivity Disorder.

Authors:  Andrea Milne Wenderlich; Constance D Baldwin; Maria Fagnano; Marybeth Jones; Jill Halterman
Journal:  J Adolesc Health       Date:  2019-08-02       Impact factor: 5.012

4.  Classification and adaptive behavior prediction of children with autism spectrum disorder based upon multivariate data analysis of markers of oxidative stress and DNA methylation.

Authors:  Daniel P Howsmon; Uwe Kruger; Stepan Melnyk; S Jill James; Juergen Hahn
Journal:  PLoS Comput Biol       Date:  2017-03-16       Impact factor: 4.475

5.  Viewpoints from families for improving transition from NICU-to-home for infants with medical complexity at a safety net hospital: a qualitative study.

Authors:  Ashwini Lakshmanan; Katrina Kubicek; Roberta Williams; Marisela Robles; Douglas L Vanderbilt; Christine B Mirzaian; Philippe S Friedlich; Michele Kipke
Journal:  BMC Pediatr       Date:  2019-07-05       Impact factor: 2.125

6.  The financial burden experienced by families of preterm infants after NICU discharge.

Authors:  Ashwini Lakshmanan; Ashley Y Song; Mandy B Belfort; Leah Yieh; Dmitry Dukhovny; Philippe S Friedlich; Cynthia L Gong
Journal:  J Perinatol       Date:  2021-09-24       Impact factor: 2.521

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.